Mankind Pharma, 543904, MANKIND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

95,266.05
47.85
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,03,194.58
N/A
6.65

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
9.92

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
4.97

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
10.09

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 47.75 48.26 50.78 65.75
P/E Ratio 48.32 47.81 45.44 35.10
Revenue 10335 12207 14717 16537
EBITDA 2816 3555 3846 4472
Net Income 1913 1991 2106 2715
ROA 17.7 10 8.7 10.6
P/B Ratio 9.60 6.64 5.90 5.08
ROE 22.77 16.8 13.98 15.74
FCFF 1852 1913 2304 2872
FCFF Yield 1.7 1.76 2.11 2.63
Net Debt -3249 6266 -392 -146
BVPS 240.24 347.37 391.07 454.5

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 2,126.59 2,007.47 5.93% 2,396.57 2,209.21 8.48% 2,529.74 2,260.47 11.91% 2,403.26 2,092.28 14.86%
Expenses 1,649.67 1,481.69 11.34% 1,655.64 1,636.04 1.20% 1,777.71 1,662.33 6.94% 1,831.06 1,594.32 14.85%
EBITDA 476.92 525.78 -9.29% 740.93 573.17 29.27% 752.03 598.14 25.73% 572.20 497.96 14.91%
EBIDTM 22.43% 26.19% 30.92% 25.94% 29.73% 26.46% 23.81% 23.80%
Other Income 219.32 84.96 158.15% 69.82 67.24 3.84% 105.76 58.11 82.00% 94.83 57.44 65.09%
Interest 162.25 4.29 3,682.05% 199.47 4.26 4,582.39% 1.92 4.31 -55.45% 6.26 1.97 217.77%
Depreciation 105.24 86.62 21.50% 87.03 89.69 -2.97% 85.42 77.01 10.92% 83.40 68.51 21.73%
PBT 428.75 519.83 -17.52% 524.25 546.46 -4.06% 770.45 574.93 34.01% 577.37 484.92 19.07%
Tax 46.29 75.39 -38.60% 107.87 83.74 28.82% 168.01 128.14 31.11% 93.12 105.14 -11.43%
PAT 382.46 444.44 -13.95% 416.38 462.72 -10.01% 602.44 446.79 34.84% 484.25 379.78 27.51%
PATM 17.98% 22.14% 17.37% 20.95% 23.81% 19.77% 20.15% 18.15%
EPS 9.27 10.77 -13.93% 10.09 11.21 -9.99% 14.60 10.83 34.81% 11.74 9.20 27.61%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 3,079.37 2,422.24 27.13% 3,230.00 2,606.95 23.90% 3,076.51 2,708.10 13.60% 2,893.42 2,578.62 12.21%
Expenses 2,396.18 1,835.94 30.52% 2,400.20 2,000.45 19.98% 2,226.47 2,025.45 9.92% 2,211.66 1,923.81 14.96%
EBITDA 683.19 586.30 16.53% 829.80 606.50 36.82% 850.04 682.65 24.52% 681.76 654.81 4.12%
EBIDTM 22.19% 24.20% 25.69% 23.26% 27.63% 25.21% 23.56% 25.39%
Other Income 251.33 92.15 172.74% 77.32 70.13 10.25% 109.43 59.98 82.44% 100.60 58.62 71.61%
Interest 190.54 9.17 1,977.86% 220.93 9.19 2,304.03% 7.10 8.62 -17.63% 10.91 6.34 72.08%
Depreciation 230.87 99.78 131.38% 192.30 109.72 75.26% 105.62 96.49 9.46% 107.74 87.35 23.34%
PBT 513.11 569.50 -9.90% 493.89 557.72 -11.44% 846.75 637.52 32.82% 663.71 619.74 7.09%
Tax 86.44 94.99 -9.00% 112.81 102.51 10.05% 190.44 129.81 46.71% 124.55 130.28 -4.40%
PAT 426.67 474.51 -10.08% 381.08 455.21 -16.28% 656.31 507.71 29.27% 539.16 489.46 10.15%
PATM 13.86% 19.59% 11.80% 17.46% 21.33% 18.75% 18.63% 18.98%
EPS 10.20 11.76 -13.27% 9.22 11.33 -18.62% 16.31 12.51 30.38% 13.39 12.15 10.21%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Net Sales 9,456.16 9,264.81 8,127.15 7,486.22 5,523.18 2,288.59 1,971.77 1,650.57 1,406.88 1,085.77 840.27 Net Sales Growth 10.35% 14.00% 8.56% 35.54% 141.34% 16.07% 19.46% 17.32% 29.57% 29.22% Cost Of Goods Sold 2,606.74 2,908.30 2,844.76 2,521.44 1,782.17 974.33 868.10 758.68 -109.37 495.66 400.20 Gross Profit 6,849.42 6,356.51 5,282.39 4,964.78 3,741.02 1,314.26 1,103.66 891.90 1,516.25 590.11 440.07 GP Margin 72.43% 68.61% 65.00% 66.32% 67.73% 57.43% 55.97% 54.04% 107.77% 54.35% 52.37% Total Expenditure 6,914.08 6,939.19 6,429.29 5,647.73 4,151.05 1,818.41 1,580.87 1,393.29 1,134.38 850.03 667.63 Power & Fuel Cost - 70.43 62.00 60.36 47.16 6.76 4.45 2.99 0.00 2.10 1.53 % Of Sales - 0.76% 0.76% 0.81% 0.85% 0.30% 0.23% 0.18% 0% 0.19% 0.18% Employee Cost - 1,982.10 1,701.38 1,462.76 1,167.42 354.31 299.05 237.02 0.00 139.94 103.21 % Of Sales - 21.39% 20.93% 19.54% 21.14% 15.48% 15.17% 14.36% 0% 12.89% 12.28% Manufacturing Exp. - 159.11 129.91 165.08 131.09 11.79 10.10 2.38 0.00 4.69 4.14 % Of Sales - 1.72% 1.60% 2.21% 2.37% 0.52% 0.51% 0.14% 0% 0.43% 0.49% General & Admin Exp. - 877.22 914.90 620.52 367.12 173.51 146.50 108.14 1,243.75 65.75 42.79 % Of Sales - 9.47% 11.26% 8.29% 6.65% 7.58% 7.43% 6.55% 88.40% 6.06% 5.09% Selling & Distn. Exp. - 806.36 607.88 686.50 482.85 168.11 237.69 272.55 0.00 139.71 111.92 % Of Sales - 8.70% 7.48% 9.17% 8.74% 7.35% 12.05% 16.51% 0% 12.87% 13.32% Miscellaneous Exp. - 135.67 168.47 131.08 173.25 129.61 14.98 11.52 0.00 2.18 111.92 % Of Sales - 1.46% 2.07% 1.75% 3.14% 5.66% 0.76% 0.70% 0% 0.20% 0.46% EBITDA 2,542.08 2,325.62 1,697.86 1,838.49 1,372.13 470.18 390.90 257.28 272.50 235.74 172.64 EBITDA Margin 26.88% 25.10% 20.89% 24.56% 24.84% 20.54% 19.82% 15.59% 19.37% 21.71% 20.55% Other Income 489.73 266.64 162.78 203.81 154.50 43.61 30.91 33.96 23.85 19.68 19.17 Interest 369.90 15.08 28.23 47.54 8.23 1.66 1.57 1.55 0.00 1.52 2.38 Depreciation 361.09 317.61 269.58 123.33 78.19 26.55 23.78 11.47 7.76 4.44 4.20 PBT 2,300.82 2,259.57 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 185.24 Tax 415.29 436.16 314.58 482.01 355.83 141.38 105.88 64.53 81.70 77.44 64.69 Tax Rate 18.05% 19.30% 20.13% 25.76% 24.71% 29.12% 26.71% 23.19% 28.31% 31.04% 34.92% PAT 1,885.53 1,823.41 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 120.55 PAT before Minority Interest 1,885.53 1,823.41 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 120.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.94% 19.68% 15.36% 18.56% 19.63% 15.04% 14.74% 12.95% 14.71% 15.84% 14.35% PAT Growth 8.76% 46.08% -10.16% 28.13% 215.04% 18.46% 35.98% 3.29% 20.27% 42.70% EPS 45.70 44.19 30.25 33.67 26.28 8.34 7.04 5.18 5.01 4.17 2.92

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 12,279.30 10,334.77 8,749.43 7,781.56 6,214.43 Net Sales Growth 19.03% 18.12% 12.44% 25.22% Cost Of Goods Sold 3,498.02 3,209.70 2,913.64 2,421.73 1,780.60 Gross Profit 8,781.28 7,125.08 5,835.79 5,359.83 4,433.82 GP Margin 71.51% 68.94% 66.70% 68.88% 71.35% Total Expenditure 9,234.51 7,798.19 6,847.50 5,791.01 4,565.32 Power & Fuel Cost - 129.30 108.96 103.13 82.53 % Of Sales - 1.25% 1.25% 1.33% 1.33% Employee Cost - 2,274.73 1,918.47 1,620.59 1,415.78 % Of Sales - 22.01% 21.93% 20.83% 22.78% Manufacturing Exp. - 174.04 150.57 189.81 140.14 % Of Sales - 1.68% 1.72% 2.44% 2.26% General & Admin Exp. - 982.88 1,000.80 626.47 451.75 % Of Sales - 9.51% 11.44% 8.05% 7.27% Selling & Distn. Exp. - 928.75 638.11 708.17 587.73 % Of Sales - 8.99% 7.29% 9.10% 9.46% Miscellaneous Exp. - 98.80 116.96 121.10 106.78 % Of Sales - 0.96% 1.34% 1.56% 1.72% EBITDA 3,044.79 2,536.58 1,901.93 1,990.55 1,649.11 EBITDA Margin 24.80% 24.54% 21.74% 25.58% 26.54% Other Income 538.68 280.86 128.57 196.03 170.95 Interest 429.48 35.05 45.76 59.80 21.16 Depreciation 636.53 398.25 325.92 166.62 118.97 PBT 2,517.46 2,384.14 1,658.81 1,960.15 1,679.93 Tax 514.24 457.59 361.56 521.64 398.58 Tax Rate 20.43% 19.19% 21.80% 26.61% 23.73% PAT 2,003.22 1,912.89 1,281.86 1,433.48 1,265.42 PAT before Minority Interest 1,983.06 1,941.77 1,309.68 1,452.96 1,293.03 Minority Interest -20.16 -28.88 -27.82 -19.48 -27.61 PAT Margin 16.31% 18.51% 14.65% 18.42% 20.36% PAT Growth 3.96% 49.23% -10.58% 13.28% EPS 48.55 46.36 31.07 34.74 30.67

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 9,623.81 7,783.91 6,540.45 4,734.27 1,555.50 1,211.29 920.72 706.73 499.84 333.59 Share Capital 40.06 40.06 40.06 40.06 20.03 20.03 20.03 20.03 14.84 14.84 Total Reserves 9,560.50 7,743.79 6,500.39 4,694.21 1,535.47 1,191.26 900.69 686.70 485.00 318.76 Non-Current Liabilities 200.54 168.12 126.98 54.11 31.36 29.46 28.49 25.41 5.78 9.09 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.71 7.27 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 111.79 88.87 73.79 56.39 4.84 2.08 1.98 4.64 0.00 0.00 Current Liabilities 1,593.36 1,419.09 2,271.27 1,078.91 593.98 540.34 474.53 364.76 233.24 171.76 Trade Payables 849.52 801.96 921.29 594.08 175.79 149.57 203.89 157.88 99.49 68.31 Other Current Liabilities 328.65 279.51 399.57 196.75 108.74 65.19 51.51 46.95 54.77 38.85 Short Term Borrowings 0.00 0.00 683.66 95.00 0.03 0.00 0.00 0.80 0.00 0.00 Short Term Provisions 415.20 337.61 266.74 193.08 309.42 325.58 219.13 159.13 78.99 64.60 Total Liabilities 11,417.71 9,371.12 8,938.70 5,867.29 2,180.84 1,781.09 1,423.74 1,096.90 738.86 514.44 Net Block 3,399.07 3,136.89 2,921.30 981.95 202.69 202.56 177.72 74.60 84.62 58.26 Gross Block 4,336.83 3,770.10 3,286.82 1,221.61 286.14 259.54 210.98 96.68 99.12 68.46 Accumulated Depreciation 937.76 633.21 365.51 239.65 83.45 56.98 33.26 22.08 14.50 10.20 Non Current Assets 5,927.30 5,854.21 5,122.99 2,777.31 568.46 529.02 383.14 195.13 248.34 148.55 Capital Work in Progress 187.58 494.78 386.57 165.57 21.37 6.44 0.43 18.11 7.30 0.21 Non Current Investment 2,190.62 2,040.76 1,657.08 1,500.86 109.51 87.66 27.01 12.47 156.42 90.08 Long Term Loans & Adv. 137.64 148.86 146.30 115.59 218.84 167.59 110.92 39.79 0.00 0.00 Other Non Current Assets 7.11 27.58 6.37 7.88 16.05 64.77 67.05 50.16 0.00 0.00 Current Assets 5,487.71 3,513.72 3,813.01 3,089.98 1,612.38 1,252.07 1,040.60 901.76 490.52 365.81 Current Investments 2,239.51 1,061.47 868.79 896.03 689.05 350.46 149.15 247.22 0.00 0.00 Inventories 1,075.59 1,032.22 1,266.69 826.91 337.19 312.67 361.73 271.93 153.55 116.63 Sundry Debtors 749.47 492.64 470.59 369.17 131.59 112.41 141.39 113.40 93.30 70.77 Cash & Bank 761.01 155.15 138.85 476.95 99.96 104.51 89.15 83.41 99.55 59.61 Other Current Assets 662.13 59.05 166.44 106.01 354.59 372.02 299.18 185.81 144.12 118.81 Short Term Loans & Adv. 572.15 713.20 901.65 414.91 351.81 372.02 299.18 184.89 144.12 118.81 Net Current Assets 3,894.35 2,094.63 1,541.74 2,011.07 1,018.40 711.73 566.07 537.00 257.28 194.06 Total Assets 11,415.01 9,367.93 8,936.00 5,867.29 2,180.84 1,781.09 1,423.74 1,096.89 738.86 514.43

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 9,363.09 7,435.22 6,155.23 4,722.00 Share Capital 40.06 40.06 40.06 40.06 Total Reserves 9,299.78 7,395.10 6,115.17 4,681.94 Non-Current Liabilities 187.34 199.24 168.68 107.33 Secured Loans 24.87 23.15 48.94 57.42 Unsecured Loans 0.00 0.00 0.25 0.25 Long Term Provisions 123.12 97.89 80.00 72.24 Current Liabilities 2,119.73 1,863.14 2,623.46 1,353.40 Trade Payables 1,102.99 1,008.18 1,076.40 666.97 Other Current Liabilities 429.58 386.05 472.89 282.77 Short Term Borrowings 151.47 115.02 794.59 158.35 Short Term Provisions 435.69 353.89 279.59 245.30 Total Liabilities 11,882.86 9,685.67 9,108.45 6,323.62 Net Block 4,539.96 4,245.28 3,582.77 1,658.94 Gross Block 5,909.75 5,233.03 4,246.54 2,160.04 Accumulated Depreciation 1,369.79 987.75 663.78 501.10 Non Current Assets 5,314.63 5,357.80 4,701.63 2,416.98 Capital Work in Progress 281.79 550.15 701.47 371.95 Non Current Investment 309.81 270.95 235.01 205.80 Long Term Loans & Adv. 163.97 187.54 163.88 158.07 Other Non Current Assets 13.79 98.51 13.09 16.72 Current Assets 6,565.52 4,324.56 4,403.84 3,906.64 Current Investments 2,258.11 1,075.47 874.46 1,306.17 Inventories 1,553.46 1,498.46 1,760.24 1,183.54 Sundry Debtors 848.28 576.42 388.17 330.61 Cash & Bank 1,197.97 453.20 405.94 700.74 Other Current Assets 707.70 64.29 170.74 109.78 Short Term Loans & Adv. 603.60 656.71 804.29 275.79 Net Current Assets 4,445.79 2,461.42 1,780.37 2,553.24 Total Assets 11,880.15 9,682.36 9,105.47 6,323.62

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 1,982.97 1,798.99 821.44 983.38 355.00 302.53 -12.85 76.28 134.50 72.38 PBT 2,259.57 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 185.24 Adjustment 161.91 227.00 -4.16 96.74 -15.62 -5.64 -21.00 -14.54 -13.65 -12.29 Changes in Working Capital -40.95 294.21 -585.61 -156.19 16.75 7.20 -185.29 -109.07 -16.87 -36.94 Cash after chg. in Working capital 2,380.53 2,084.05 1,281.67 1,380.76 486.71 398.02 71.94 164.97 218.94 136.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -397.55 -285.06 -460.22 -397.38 -131.71 -95.49 -84.79 -88.69 -84.44 -63.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,919.12 -1,040.61 -1,360.27 -1,127.16 -358.15 -285.77 20.74 -87.97 -84.29 -57.53 Net Fixed Assets -259.53 -591.49 -2,286.21 -1,079.67 -41.53 -54.57 -96.62 -8.37 -37.75 -59.17 Net Investments -1,327.90 -576.36 -128.98 -1,598.33 -360.44 -261.96 83.53 -103.27 -66.34 -85.29 Others -331.69 127.24 1,054.92 1,550.84 43.82 30.76 33.83 23.67 19.80 86.93 Cash from Financing Activity -8.68 -710.41 578.63 88.87 -1.41 -1.40 -2.15 -4.46 -10.27 -12.71 Net Cash Inflow / Outflow 55.17 47.96 39.81 -54.91 -4.55 15.36 5.74 -16.14 39.94 2.14 Opening Cash & Equivalents 134.13 86.17 46.36 77.50 104.51 89.15 83.41 99.55 59.61 57.47 Closing Cash & Equivalent 189.20 134.13 86.17 22.58 99.96 104.51 89.15 83.41 99.55 59.61

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 2,152.45 1,813.30 919.78 1,137.24 PBT 2,399.36 1,671.24 1,974.60 1,691.61 Adjustment 212.20 298.43 30.81 -5.66 Changes in Working Capital 20.42 166.73 -586.12 -94.63 Cash after chg. in Working capital 2,631.98 2,136.40 1,419.29 1,591.32 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -479.53 -323.10 -499.51 -454.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,081.69 -1,054.13 -1,369.14 -1,222.21 Net Fixed Assets -259.53 -591.49 -2,286.21 Net Investments -1,327.90 -576.36 -128.98 Others -494.26 113.72 1,046.05 Cash from Financing Activity 5.27 -739.73 604.62 -7.81 Net Cash Inflow / Outflow 76.02 19.44 155.26 -92.78 Opening Cash & Equivalents 304.82 283.06 127.33 219.73 Closing Cash & Equivalent 382.01 304.82 283.06 127.33

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 239.66 194.31 163.27 118.18 776.61 604.76 459.68 352.84 336.89 224.80 ROA 17.54% 13.63% 18.77% 20.90% 17.38% 18.13% 16.96% 22.54% 27.45% 40.07% ROE 20.98% 17.43% 24.65% 25.86% 24.88% 27.26% 26.26% 34.29% 41.28% 66.91% ROCE 26.13% 21.20% 31.84% 34.16% 35.22% 37.34% 34.37% 47.66% 59.45% 99.58% Fixed Asset Turnover 2.37 2.40 3.45 4.73 8.39 8.38 10.73 14.37 12.96 21.61 Receivable days 23.55 20.75 19.69 26.03 19.46 23.49 28.17 26.81 27.58 19.61 Inventory Days 39.97 49.52 49.10 44.95 51.82 62.42 70.06 55.19 45.41 33.51 Payable days 103.63 110.55 109.68 110.73 37.38 44.99 47.49 0.00 37.71 27.75 Cash Conversion Cycle -40.11 -40.28 -40.89 -39.75 33.90 40.92 50.75 82.01 35.28 25.36 Total Debt/Equity 0.00 0.00 0.10 0.02 0.00 0.00 0.00 0.00 0.01 0.02 Interest Cover 150.83 56.36 40.37 175.93 294.17 253.23 180.56 0.00 165.50 78.96

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 233.15 185.61 153.65 117.88 ROA 18.01% 13.94% 18.83% 22.79% ROE 23.15% 19.27% 26.72% 31.51% ROCE 28.38% 23.49% 33.96% 39.97% Fixed Asset Turnover 1.93 1.92 2.52 3.00 Receivable days 24.18 19.33 16.25 25.31 Inventory Days 51.80 65.31 66.57 61.16 Payable days 120.04 130.57 131.38 144.73 Cash Conversion Cycle -44.05 -45.92 -48.56 -58.26 Total Debt/Equity 0.02 0.02 0.14 0.05 Interest Cover 69.46 37.52 34.02 80.96

Top Investors:

sbi large & midcap fund

government pension fund global

axis mutual fund trustee limited a/c axis mutual f

sbi life insurance co. ltd.

nps trust- a/c sbi pension fund pvt ltd apy fund s

Annual Reports:

News Update:

Mankind Pharma gets ESG score of 38.98 from ISS ESG
5th Jun 2025, 10:30 AM

The company has not verified any data on which this rating has been issued
Read More
Mankind Pharma reports 11% fall in Q4 consolidated net profit
22nd May 2025, 12:30 PM

The total consolidated income of the company increased by 32.47% at Rs 3,330.70 crore for Q4FY25
Read More
Mankind Pharma gets nod to incorporate wholly owned subsidiary in Sri Lanka
22nd May 2025, 11:09 AM

The Board of Directors of the Company at its meeting held on May 21, 2025, has approved the same
Read More
Mankind Pharma gets nod to incorporate wholly owned subsidiary in Russia
15th Apr 2025, 10:30 AM

The Board of Directors of the Company at its meeting held on April 14, 2025, has inter-alia, considered and approved the same
Read More

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: